Heart disease and stroke statistics—2019 update: a report from the American Heart Association

EJ Benjamin, P Muntner, A Alonso, MS Bittencourt… - Circulation, 2019 - Am Heart Assoc
Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …

Heart disease and stroke statistics—2018 update: a report from the American Heart Association

EJ Benjamin, SS Virani, CW Callaway… - Circulation, 2018 - Am Heart Assoc
Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

Clinical use of intracoronary imaging. Part 2: Acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: An …

TW Johnson, L Räber, C Di Mario… - European heart …, 2019 - academic.oup.com
This consensus document is the second of two reports summarizing the views of an expert
panel organized by the European Association of Percutaneous Cardiovascular Interventions …

Heart disease and stroke statistics—2020 update: a report from the American Heart Association

SS Virani, A Alonso, EJ Benjamin, MS Bittencourt… - Circulation, 2020 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …

Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations

M Galli, F Franchi, F Rollini, LH Cavallari… - Expert review of …, 2021 - Taylor & Francis
Introduction Clopidogrel is the most frequently utilized P2Y12 inhibitor and is characterized
by broad interindividual response variability resulting in impaired platelet inhibition and …

Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome―The ODYSSEY J-IVUS Trial―

J Ako, K Hibi, K Tsujita, T Hiro, Y Morino… - Circulation …, 2019 - jstage.jst.go.jp
Background: In patients with acute coronary syndrome (ACS), alirocumab reduced the risk of
recurring ischemic events. ODYSSEY J-IVUS assessed the effect of alirocumab on coronary …

One-Year Outcome After Percutaneous Coronary Intervention for Acute Coronary Syndrome―An Analysis of 20,042 Patients From a Japanese Nationwide Registry―

M Sawano, S Kohsaka, H Ishii, Y Numasawa… - Circulation …, 2021 - jstage.jst.go.jp
Background: Acute coronary syndrome (ACS) hospital survivors experience a wide array of
late adverse cardiac events, despite considerable advances in the quality of care. We …

Deep-learning-based risk stratification for mortality of patients with acute myocardial infarction

J Kwon, KH Jeon, HM Kim, MJ Kim, S Lim, KH Kim… - PloS one, 2019 - journals.plos.org
Objective Conventional risk stratification models for mortality of acute myocardial infarction
(AMI) have potential limitations. This study aimed to develop and validate deep-learning …

Risk stratification in acute coronary syndrome by comprehensive morphofunctional assessment with optical coherence tomography

H Hong, H Jia, M Zeng, JL Gutiérrez-Chico, Y Wang… - JACC: Asia, 2022 - jacc.org
Background Artificial intelligence enables simultaneous evaluation of plaque morphology
and computational physiology from optical coherence tomography (OCT). Objectives This …

[HTML][HTML] Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper

P Sabouret, G Lemesle… - Archives of Medical …, 2022 - ncbi.nlm.nih.gov
Results The International Collaborative Group underlines the need of a shared collaborative
approach, and a care plan individualized to the patient's risk profile for both ischaemia and …